|
|
Drugs for Stomach Carcinoma in Situ (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show all 43)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Fentanyl | approved, illicit, investigational, vet_approved | Phase 3 | 821 | 437-38-7 | 3345 | 1-Phenethyl-4-(N-phenylpropionamido)piperidine 1-Phenethyl-4-N-propionylanilinopiperidine 1-phenethyl-4-N-propionylanilinopiperidine 437-38-7 5-22-08-00049 (Beilstein Handbook Reference) 80832-90-2 990-73-8 (citrate) AC1L1FQ2 Actiq BIDD:GT0555 BRN 0494484 CHEBI:119915 CHEMBL596 CID3345 D00320 DB00813 Duragesic Duragesic (TN) Duragesic-100 Duragesic-12 Duragesic-25 Duragesic-50 Duragesic-75 Durogesic EINECS 207-113-6 Fentanest Fentanil Fentanil [DCIT] Fentanila Fentanila [INN-Spanish] Fentanilo Fentanyl Fentanyl (JAN/USAN/INN) Fentanyl CII Fentanyl [INN:BAN] Fentanyl citrate Fentanyl-100 Fentanyl-12 Fentanyl-25 | Fentanyl-50 Fentanyl-75 Fentanylum Fentanylum [INN-Latin] HSDB 3329 IONSYS JNS020QD L001275 LS-124439 Matrifen MolPort-003-847-369 N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide N-(1-Phenethyl-4-piperidyl)propionanilide N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide N-(1-phenethyl-4-piperidyl)propionanilide N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide N-Phenethyl-4-(N-propionylanilino)piperidine N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide N-phenethyl-4-(N-propionylanilino)piperidine N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide NCGC00168252-01 Nasalfent Oprea1_152073 Oprea1_207148 PDSP1_000860 PDSP2_000846 Pentanyl Phentanyl Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI) R 4263 Rapinyl Sentonil Sublimase Sublimaze UNII-UF599785JZ fentanyl | |
| | 2 | | Liver Extracts | | Phase 3 | 4067 | | | | 3 | | Narcotics | | Phase 3 | 3646 | | | | 4 | | Peripheral Nervous System Agents | | Phase 3 | 23689 | | | | 5 | | Adjuvants, Anesthesia | | Phase 3 | 1674 | | | | 6 | | Central Nervous System Depressants | | Phase 3 | 13403 | | | | 7 | | pancreatic polypeptide | | Phase 3 | 20 | | | | 8 | | Analgesics | | Phase 3 | 11733 | | | | 9 | | Anesthetics | | Phase 3 | 9596 | | | | 10 | | Analgesics, Opioid | | Phase 3 | 3238 | | | | 11 | | Anesthetics, General | | Phase 3 | 2934 | | | | 12 | | Anesthetics, Intravenous | | Phase 3 | 2538 | | | | 13 | | Cola | Nutraceutical | Phase 3 | 1946 | | | | 14 | | Oxaliplatin | approved, investigational | Phase 1, Phase 2 | 1460 | 61825-94-3 | 5310940, 9887054, 6857599, 9887054, 43805 | CHEMBL1201055 CID9887054 D01790 DACPLAT Diaminocyclohexane Oxalatoplatinum Eloxatin Eloxatin (TN) Elplat Foloxatine L-OHP Oxalatoplatin | Oxalatoplatinum Oxaliplatin (JAN/USAN/INN) Oxaliplatin [Usan:Inn:Ban] Oxaliplatino [Spanish] Oxaliplatinum [Latin] Oxaloplatine [French] Oxaloplatino [Spanish] Transplatin oxaliplatin oxaliplatine oxaliplatino oxaliplatinum | |
| | 15 | | Levoleucovorin | approved | Phase 1, Phase 2 | 728 | 68538-85-2 | | (6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid (6S)-5-formyltetrahydrofolic acid (6S)-Folinic acid (6S)-Leucovorin | (S)-Leucovorin Citrovorum factor L-Folinic acid Levofolene Levofolinic acid N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid |
| | 16 | | Fluorouracil | approved | Phase 1, Phase 2 | 1856 | 51-21-8 | 3385 | 1-fluoro-1h-pyrimidine-2,4-dione 1004-03-1 1upf 2,4-Dihydroxy-5-fluoropyrimidine 2,4-Dioxo-5-fluoropryimidine 2,4-Dioxo-5-fluoropyrimidine 47576_FLUKA 4921-97-5 5 FU Lederle 5 FU medac 5 Fluorouracil 5 Fluorouracil biosyn 5 HU Hexal 5-FU 5-FU (TN) 5-FU Lederle 5-FU medac 5-Faracil 5-Fluor-2,4(1H,3H)-pyrimidindion 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech] 5-Fluor-2,4-dihydroxypyrimidin 5-Fluor-2,4-dihydroxypyrimidin [Czech] 5-Fluor-2,4-pyrimidindiol 5-Fluor-2,4-pyrimidindiol [Czech] 5-Fluoracil 5-Fluoracil [German] 5-Fluoracyl 5-Fluoro-2,4(1H,3H)-pyrimidinedione 5-Fluoro-2,4-pyrimidinedione 5-Fluoropyrimidin-2,4-diol 5-Fluoropyrimidine-2,4-dione 5-Fluorouracil 5-Fluorouracil-biosyn 5-Fluoruracil 5-Fluoruracil [German] 5-Fluracil 5-Ftouracyl 5-HU Hexal 5-fluoro uracil 5-fluoro-1H-pyrimidine-2,4-dione 5-fluoropyrimidine-2,4(1H,3H)-dione 5-fluorouracil 51-21-8 5FU 79108-01-3 AC-11201 AC1L1FTE AC1Q4N2X AI3-25297 AKOS000119162 AKOS003237897 AccuSite Actino-Hermal Adrucil Adrucil (TN) Allergan Brand of Fluorouracil Arumel BB_NC-0576 BSPBio_002048 C07649 C4H3FN2O2 CCRIS 2582 CHEBI:46345 CHEMBL185 CID3385 CPD0-1327 CPD000038082 CSP Brand of Fluorouracil Carac Carac (TN) Carzonal Cinco FU Cytosafe D005472 D00584 DB00544 Dakota Brand of Fluorouracil Dakota, Fluorouracile Dermatech Brand of Fluorouracil Dermik Brand of Fluorouracil DivK1c_000054 EINECS 200-085-6 EU-0100536 Effluderm Effluderm (free base) Efudex Efudix Efurix F 6627 F0151 F6627_SIGMA F8423_SIGMA FT-0082524 FU Ferrer Brand of Fluorouracil Fiverocil Fluoro Uracil Fluoro Uracile ICN Fluoro-Uracile ICN Fluoro-uracile Fluoro-uracilo Fluoroblastin Fluoroplex Fluoroplex (TN) Fluorouracil Fluorouracil (JP15/USP/INN) Fluorouracil GRY Fluorouracil Mononitrate Fluorouracil Monopotassium Salt Fluorouracil Monosodium Salt Fluorouracil Potassium Salt Fluorouracil Teva Brand Fluorouracil [USAN:INN:BAN:JAN] | Fluorouracil-GRY Fluorouracile Fluorouracile Dakota Fluorouracile [DCIT] Fluorouracilo Fluorouracilo Ferrer Far Fluorouracilo [INN-Spanish] Fluorouracilum Fluorouracilum [INN-Latin] Fluoruracil Fluouracil Flurablastin Fluracedyl Fluracil Fluracilum Fluri Fluril Fluro Uracil Fluroblastin Flurodex Flurouracil Flurox Ftoruracil Gry Brand of Fluorouracil HMS1920O18 HMS2090I04 HMS2091F19 HMS500C16 HSDB 3228 Haemato Brand of Fluorouracil Haemato fu Haemato-fu Hexal Brand of Fluorouracil I07-0022 ICN Brand of Fluorouracil IDI1_000054 IN1335 KBio1_000054 KBio2_001321 KBio2_003889 KBio2_006457 KBio3_001268 KBioGR_001253 KBioSS_001321 Kecimeton LS-153 Lopac-F-6627 Lopac0_000536 MLS000069498 MLS002415705 MolPort-000-156-102 MolPort-003-990-447 MolPort-004-758-143 MolPort-004-758-144 MolPort-005-861-486 NCGC00015442-01 NCGC00015442-03 NCGC00015442-10 NCGC00091349-01 NCGC00091349-02 NCGC00091349-03 NCGC00091349-04 NCGC00091349-05 NCGC00091349-07 NCGC00091349-08 NCI60_001652 NINDS_000054 NSC 19893 NSC-19893 NSC19893 Neocorp Brand of Fluorouracil Neofluor Onkofluor Onkoworks Brand of Fluorouracil Phthoruracil Phtoruracil Queroplex Ribofluor Riemser Brand of Fluorouracil Ro 2-9757 Ro-2-9757 Roche Brand of Fluorouracil S1209_Selleck SAM002264615 SMR000038082 SPBio_000291 SPECTRUM1500305 STK297802 Spectrum2_000076 Spectrum3_000434 Spectrum4_000557 Spectrum5_000718 Spectrum_000841 T5233394 TL8006093 Teva Brand of Fluorouracil Timazin U 8953 U-8953 UNII-U3P01618RT UPCMLD-DP130 UPCMLD-DP130:001 URF Ulup WLN: T6MVMVJ EF ZINC00897110 biosyn Brand of Fluorouracil fluorouracil inhibits thymilidate synthetase medac Brand of Fluorouracil nchembio.90-comp3 nchembio809-comp6 ribosepharm Brand of Fluorouracil tetratogen | |
| | 17 | | Cisplatin | approved | Phase 2 | 2770 | 15663-27-1 | 84093, 441203, 2767 | (SP-4-1)-diamminedichloridoplatinum (SP-4-1)-diamminedichloroplatinum (SP-4-2)-diamminedichloridoplatinum (SP-4-2)-diamminedichloroplatinum Abiplatin Biocisplatinum Briplatin CACP CDDP CHEBI:35852 CID441203 CPD0-1392 CPDC CPDD Carboquone Cis Pt II Cis-DDP Cis-Diaminedichloroplatinum Cis-Diamminedichloroplatinum Cismaplat Cisplatine Cisplatino Cisplatinum Cisplatyl Citoplationo DB00515 DDP DDPT Diamminedichloroplatinum | EU-0100918 Lederplatin Neoplatin Peyrone's chloride Peyrone's salt Plastin Platamine Platiblastin Platidiam Platinex Platinol Platinol-AQ Platinoxan Platinum Ammine Chloride Platinum Ammonium Chloride Platinum Diamine Dichloride Randa Trans-DDP Trans-Diaminedichloroplatinum Trans-Diamminedichloroplatinum Trans-Dichlorodiammine Platinum Trans-Platinumdiammine Dichloride cis-DDP cis-Diamminedichloroplatinum cis-Dichlorodiammineplatinum(II) cis-[PtCl2(NH3)2] cis-diamminedichloridoplatinum(II) cis-diamminedichloroplatinum(II) nchembio773-comp1 trans-diamminedichloridoplatinum(II) | |
| | 18 | | leucovorin | approved, Nutraceutical | Phase 1, Phase 2 | 3235 | 58-05-9 | 54575, 6560146, 143 | (5-formyl-5,6,7,8-tetrahydropteroyl)glutamate (6R,S)-5-Formyltetrahydrofolate 10-Formyl-7,8-dihydrofolate 10-Formyl-7,8-dihydrofolic acid 5-Formyl-5,6,7,8-tetrahydrofolate 5-Formyl-5,6,7,8-tetrahydrofolic acid 5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid 5-Formyltetrahydrofolate 5-Formyltetrahydrofolic acid 5-Formyltetrahydropteroylglutamate 5-Formyltetrahydropteroylglutamic acid 5-formyltetrahydrofolic acid Acide folinique Calcium citrovorum factor Calcium folinate Citrovorum factor Folinate Folinic acid Folinic acid calcium salt | Folinic acid calcium salt USP27 Folinic acid-SF L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid L-Leucovorin L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid L-leucovorin Leucal Leucovorin calcium Leucovorin folinic acid Leucovorinum Leukovorin Levoleucovorin N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid N5-Formyl-5,6,7,8-tetrahydrofolate N5-Formyl-5,6,7,8-tetrahydrofolic acid N5-Formyl-THF N5-Formyltetrahydrofolate N5-Formyltetrahydrofolic acid Welcovorin Wellcovorin folinate |
| | 19 | | Folic Acid | approved, nutraceutical, vet_approved | Phase 1, Phase 2 | 4392 | 59-30-3 | 6037 | (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid 01769_FLUKA 2d0k 33609-88-0 36653-55-1 (mono-potassium salt) 59-30-3 6484-89-5 (mono-hydrochloride salt) AC-11682 AC1L1LNX AI3-26387 AKOS000503224 ARONIS014410 Acfol (Spain) Acide folique Acide folique [INN-French] Acido folico Acido folico [INN-Spanish] Acidum folicum Acidum folicum [INN-Latin] Acifolic Antianemia factor Apo-Folic BIDD:ER0563 BIDD:GT0641 BIF0608 BPBio1_000654 BSPBio_000594 BSPBio_002338 C00504 C20H20N6O6 CAS-59-30-3 CCRIS 666 CHEBI:27470 CHEMBL1622 CID6037 CPD000471860 Cytofol D00070 DB00158 DivK1c_000494 Dosfolat B activ EINECS 200-419-0 F0043 F7876_SIAL F7876_SIGMA F8758_SIGMA F8798_SIAL F8890_SIGMA FOL Facid Factor U Folacid Folacin Folaemin Folaemin [Netherlands] Folan Folasic (Australia) Folate Folbal Folcidin Folcidin (VAN) Folcysteine Foldine Foldine [France] Folettes Foliamin Folic Folic acid Folic acid (JP15/USP/INN) Folic acid (TN) Folic acid [BAN:INN:JAN] Folic acid [INN:BAN:JAN] Folic acid dihydrate Folicet Folicet (TN) Folico Folico (Italy) Folina Folina (Italy) Folipac Folsaeure | Folsan Folsaure Folsav Folvite Folvron Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L HMS1921D20 HMS2092N17 HMS501I16 HSDB 2002 IDI1_000494 InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s Incafolic KBio1_000494 KBio2_001861 KBio2_004429 KBio2_006997 KBio3_001558 KBioGR_002222 KBioSS_001861 Kyselina listova Kyselina listova [Czech] LS-2157 Liver Lactobacillus casei factor MLS001304016 MLS001335861 Millafol Mission prenatal Mittafol MolPort-004-285-551 N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid N-Pteroyl-L-glutamic acid N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid NCGC00016265-01 NCGC00142391-01 NINDS_000494 NSC 3073 Nifolin Nifolin [Denmark] Novofolacid Novofolacid [Canada] PGA PGA (VAN) Prestwick3_000627 Prestwick_230 PteGlu Pteroyl-L-glutamate Pteroyl-L-glutamic acid Pteroyl-L-monoglutamate Pteroyl-L-monoglutamic acid Pteroylglutamate Pteroylglutamic acid Pteroylmonoglutamate Pteroylmonoglutamic acid SAM002264616 SDCCGMLS-0066738.P001 SMP2_000137 SMR000471860 SPBio_001357 SPECTRUM1502020 Serum Folate Level Spectrum2_001459 Spectrum3_000749 Spectrum4_001751 Spectrum5_000602 Spectrum_001381 UNII-935E97BOY8 Usaf cb-13 Vitamin B11 Vitamin B9 Vitamin Bc Vitamin Be Vitamin M bmse000299 folic acid nchembio.108-comp10 | |
| | 20 | | Vitamin B Complex | | Phase 1, Phase 2 | 4337 | | | | 21 | | Micronutrients | | Phase 1, Phase 2 | 6001 | | | | 22 | | Vitamins | | Phase 1, Phase 2 | 5282 | | | | 23 | | Trace Elements | | Phase 1, Phase 2 | 6001 | | | | 24 | | Protective Agents | | Phase 1, Phase 2 | 7443 | | | | 25 | | Immunosuppressive Agents | | Phase 1, Phase 2 | 13086 | | | | 26 | | Antimetabolites | | Phase 1, Phase 2 | 12054 | | | | 27 | | Antimetabolites, Antineoplastic | | Phase 1, Phase 2 | 7361 | | | | 28 | | Bone Density Conservation Agents | | Phase 1, Phase 2 | 3376 | | | | 29 | | Antidotes | | Phase 1, Phase 2 | 1071 | | | | 30 | | Calcium, Dietary | | Phase 1, Phase 2 | 5713 | | | | 31 | | Folate | Nutraceutical | Phase 1, Phase 2 | 4392 | | | | 32 | | Vitamin B9 | Nutraceutical | Phase 1, Phase 2 | 4392 | | | | 33 | | Paclitaxel | approved, vet_approved | Phase 1 | 2864 | 33069-62-4 | 36314 | (2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester 12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine 157069-30-2 33069-62-4 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv. 7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv. 7-Epi-Paclitaxel 7-Epi-Taxol 7-Epipaclitaxel 7-Epitaxol 7-epi-Paclitaxel 7-epi-Taxol AB00513812 ABI 007 ABI-007 ABI007 AC-675 AC1L1IOG AC1L1VJI AC1L9AVF ACon1_002231 ANX-513 Abraxane Abraxane (TN) Abraxane I.V. Suspension Abraxis BioScience brand of albumin-bound paclitaxel Ambotz33069-62-4 Anzatax Asotax BIDD:PXR0046 BMS 181339-01 BMS-181339 BMS-181339-01 BPBio1_000320 BRD-A23723433-001-01-2 BRD-A28746609-001-04-0 BRD-K62008436-001-03-1 BSPBio_000290 BSPBio_001152 BSPBio_002614 Bio-0076 Bio1_000362 Bio1_000851 Bio1_001340 Bio2_000416 Bio2_000896 Bristaxol C07394 C466458 C47H51NO14 CCRIS 8143 CHEBI:103439 CHEBI:45863 CHEMBL100910 CHEMBL418410 CHEMBL48 CID36314 CID441276 CID4666 CID6713921 CID6915727 CPD-8718 Capxol D00491 DB01229 DHP-107 DHP-208 DRG-0190 DTS-301 DivK1c_000441 EU-0101201 Ebetaxel EmPAC Epitaxol Genaxol Genetaxyl Genexol Genexol-PM HMS1362J13 HMS1568O12 HMS1792J13 HMS1922K08 HMS1990J13 HMS2090D07 HMS2093K15 HMS501G03 HSDB 6839 I06-0014 IDI1_000441 IDI1_002171 Intaxel KBio1_000441 KBio2_000492 KBio2_002016 KBio2_002509 KBio2_003060 KBio2_004584 KBio2_005077 KBio2_005628 KBio2_007152 KBio2_007645 KBio3_000903 KBio3_000904 KBio3_001834 KBio3_002987 KBioGR_000492 KBioGR_001893 | KBioGR_002509 KBioSS_000492 KBioSS_002016 KBioSS_002517 LMPR0104390001 LS-31070 LipoPac Lopac0_001201 MBT 0206 MEGxp0_001940 MLS000863266 MLS001077297 MLS002154218 MLS002172439 MLS002695976 MPI-5018 Micellar Paclitaxel Mitotax MolPort-001-742-627 MolPort-003-665-783 MolPort-003-932-365 NCGC00024995-02 NCGC00024995-03 NCGC00024995-04 NCGC00024995-05 NCGC00024995-06 NCGC00024995-07 NCGC00164367-01 NCGC00164367-02 NCGC00164367-03 NCI60_000601 NINDS_000441 NK 105 NP-010981 NSC 125973 NSC-125973 NSC125973 NSC358882 Nanotaxel Neuro_000060 Nova-12005 OAS-PAC-100 OncoGel Onxal Onxol Onxol, Taxol, Nov-Onxol, Paclitaxel P1632 Paclical Pacligel Paclitaxel Paclitaxel (JAN/USP) Paclitaxel (JAN/USP/INN) Paclitaxel (Taxol) Paclitaxel [USAN:INN:BAN] Paxceed Paxene Paxoral Plaxicel Praxel Prestwick0_000155 Prestwick1_000155 Prestwick2_000155 Prestwick3_000155 Probes2_000350 QW 8184 S-8184 Paclitaxel Injectable Emulsion S1150_Selleck SDCCGMLS-0066823.P001 SDP-013 SMP1_000228 SMR000394086 SMR000857385 SPBio_000943 SPBio_002229 SPECTRUM1503908 ST50306996 Spectrum2_000872 Spectrum3_001057 Spectrum4_001197 Spectrum5_001491 Spectrum_001536 T 7402 T1912_SIGMA T7191_SIGMA T7402_SIGMA TA1 TAXOL (TN) TAXOL, 10-EPI, TXL TaxAlbin Taxol Taxol A Taxol Konzentrat Taxol.RTM. (Registered Trademark) UNII-P88XT4IS4D UPCMLD-DP108:001 UPCMLD-DP108:002 Vascular Wrap Xorane Yewtaxan abi-007 albumin-bound paclitaxel cMAP_000068 nab-paclitaxel nchembio.188-comp1 nchembio.2007.34-comp9 nchembio.215-comp9 nchembio853-comp6 paclitaxel weekly paclitaxel |
| | 34 | | Tegafur | approved | Phase 1 | 96 | 17902-23-7 | | | 35 | | Immunoglobulins | | Phase 1 | 6394 | | | | 36 | | Albumin-Bound Paclitaxel | | Phase 1 | 2864 | | | | 37 | | Antibodies | | Phase 1 | 6394 | | | | 38 | | Antimitotic Agents | | Phase 1 | 5657 | | | | 39 | | s 1 (combination) | | Phase 1 | 378 | | | Gimeracil / oteracil / tegafur TS 1 | |
| | 40 | | Antineoplastic Agents, Phytogenic | | Phase 1 | 5602 | | | | 41 | | Trastuzumab | approved, investigational | | 784 | 180288-69-1 | 9903 | 180288-69-1 Anti HER2 Anti-erbB2 Monoclonal Antibody D03257 HER2 Monoclonal Antibody Herceptin | Herceptin (TN) Ig gamma-1 chain C region Trastuzumab Trastuzumab (INN) Trastuzumab (genetical recombination) Trastuzumab (genetical recombination) (JAN) trastuzumab | |
| | 42 | | nivolumab | approved | | 424 | 946414-94-4 | | | MDX-1106 ONO-4538 nivolumab |
| | 43 | | Mitogens | | | 1617 | | |
Interventional clinical trials: (show all 18)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Difference of Gastric Microbiota in the Process of Correa's Model. | Recruiting | NCT02833363 | Phase 4 | | 2 | Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain | Completed | NCT00538850 | Phase 3 | | 3 | C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer | Unknown status | NCT02344810 | Phase 1, Phase 2 | | 4 | A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients | Recruiting | NCT01100801 | Phase 2 | | 5 | A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 Expression | Recruiting | NCT02512237 | Phase 1 | | 6 | Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers | Not yet recruiting | NCT03162510 | Phase 1 | | 7 | Prognostic Value and Clinical Pathology of c-MET Expression and Amplification in Gastric Carcinoma | Unknown status | NCT02002416 | | | 8 | Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma | Unknown status | NCT01642797 | | | 9 | Clinical Relevance of ROS (V-ros UR2 Sarcoma Virus Oncogene Homolog) Aberrations in Solid Tumours | Unknown status | NCT01596374 | | | 10 | Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma | Completed | NCT02731313 | | | 11 | Trastuzumab Based Therapy in HER2 Positive AGC | Completed | NCT03024450 | | | 12 | Esophageal Cytology With FISH in Detecting Esophageal Cancer | Completed | NCT02100189 | | | 13 | Biomarker-Integrated Umbrella, Advanced Gastric Cancer | Recruiting | NCT02951091 | | | 14 | Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer | Recruiting | NCT02610218 | | | 15 | PCLE for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma | Recruiting | NCT02515721 | | | 16 | Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN) | Recruiting | NCT01104077 | | | 17 | Malignant Progression of Anal Intra-epithelial Neoplasia in a Cohort of Patients | Recruiting | NCT01877135 | | | 18 | Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus | Terminated | NCT00386594 | |
|
